Development of Radiotracers for Breast Cancer—The Tumor Microenvironment as an Emerging Target
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of Radiotracers for Breast Cancer—The Tumor Microenvironment as an Emerging Target
Authors
Keywords
-
Journal
Cells
Volume 9, Issue 10, Pages 2334
Publisher
MDPI AG
Online
2020-10-23
DOI
10.3390/cells9102334
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome
- (2020) Elisa D’Arcangelo et al. BRITISH JOURNAL OF CANCER
- Targeted brain tumor radiotherapy using an Auger emitter
- (2020) Giacomo Pirovano et al. CLINICAL CANCER RESEARCH
- The prognostic value of the tumor–stroma ratio is most discriminative in patients with grade III or triple‐negative breast cancer
- (2020) Kiki M.H. Vangangelt et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer
- (2020) Sevda Salimifard et al. PATHOLOGY RESEARCH AND PRACTICE
- Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice
- (2020) Sharmilla Devi Jayasingam et al. Frontiers in Oncology
- Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies
- (2020) Janik Puttemans et al. Cancers
- Interactions between cancer-associated fibroblasts and tumor cells promote MCL-1 dependency in estrogen receptor-positive breast cancers
- (2019) K. Louault et al. ONCOGENE
- FAPI-PET/CT: Mean intensity of tracer-uptake (SUV) in 28 different kinds of cancer
- (2019) Clemens Kratochwil et al. JOURNAL OF NUCLEAR MEDICINE
- Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer
- (2019) Jana Plava et al. Molecular Cancer
- Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC) – Recommendations for Daily Routine Practice
- (2019) Andreas Schneeweiss et al. GEBURTSHILFE UND FRAUENHEILKUNDE
- Ontogeny of Tumor-Associated Macrophages
- (2019) Marie Laviron et al. Frontiers in Immunology
- A Review of the Hereditary Component of Triple Negative Breast Cancer: High- and Moderate-Penetrance Breast Cancer Genes, Low-Penetrance Loci, and the Role of Nontraditional Genetic Elements
- (2019) Darrell L. Ellsworth et al. Journal of Oncology
- A 89Zr-HDL PET tracer monitors response to a CSF1R inhibitor
- (2019) Christian Mason et al. JOURNAL OF NUCLEAR MEDICINE
- Folate Receptor α-Targeted 89Zr-M9346A Immuno-PET for Image-Guided Intervention with Mirvetuximab Soravtansine in Triple-Negative Breast Cancer
- (2019) Gyu Seong Heo et al. MOLECULAR PHARMACEUTICS
- Recent Advances in Nuclear Imaging of Receptor Expression to Guide Targeted Therapies in Breast Cancer
- (2019) Salvatore et al. Cancers
- 177Lu-NM600 targeted radionuclide therapy extends survival in syngeneic murine models of triple-negative breast cancer
- (2019) Reinier Hernandez et al. JOURNAL OF NUCLEAR MEDICINE
- Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.)
- (2018) Makoto Hosono et al. ANNALS OF NUCLEAR MEDICINE
- Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapy
- (2018) Yuri Tolkach et al. BREAST CANCER RESEARCH AND TREATMENT
- A peek into cancer-associated fibroblasts: origins, functions and translational impact
- (2018) Valerie S. LeBleu et al. Disease Models & Mechanisms
- Contribution of Tumor Endothelial Cells in Cancer Progression
- (2018) Kyoko Hida et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Development of quinoline based theranostic ligands for the targeting of fibroblast activation protein
- (2018) Thomas Lindner et al. JOURNAL OF NUCLEAR MEDICINE
- A new method for tumor imaging by targeting cancer associated fibroblasts
- (2018) Anastasia Loktev et al. JOURNAL OF NUCLEAR MEDICINE
- Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid–Mediated Pretargeting: In Vivo Proof of Principle
- (2018) Kristina Westerlund et al. JOURNAL OF NUCLEAR MEDICINE
- Evaluation of an Anti-HER2 Nanobody Labeled with 225Ac for Targeted α-Particle Therapy of Cancer
- (2018) Marek Pruszynski et al. MOLECULAR PHARMACEUTICS
- Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics
- (2018) Ellen Puré et al. ONCOGENE
- Treatment response assessment with (R)-[11CPAQ PET in the MMTV-PyMT mouse model of breast cancer
- (2018) T. Tegnebratt et al. EJNMMI Research
- The prognostic value of tumour–stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review
- (2018) C. J. H. Kramer et al. BREAST CANCER RESEARCH AND TREATMENT
- Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
- (2017) M.J. Duffy et al. EUROPEAN JOURNAL OF CANCER
- Review: Receptor Targeted Nuclear Imaging of Breast Cancer
- (2017) Simone Dalm et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
- (2017) Gary A. Ulaner et al. JOURNAL OF NUCLEAR MEDICINE
- Improved Estrogen Receptor Assessment by PET Using the Novel Radiotracer18F-4FMFES in Estrogen Receptor–Positive Breast Cancer Patients: An Ongoing Phase II Clinical Trial
- (2017) Michel Paquette et al. JOURNAL OF NUCLEAR MEDICINE
- Tumor Uptake of64Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer
- (2017) Joanne E. Mortimer et al. JOURNAL OF NUCLEAR MEDICINE
- Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical Evaluation
- (2017) Zhengyuan Zhou et al. MOLECULAR IMAGING AND BIOLOGY
- Circulating levels of angiogenesis-related growth factors in breast cancer: A study to profile proteins responsible for tubule formation
- (2017) Gemma A. Barron et al. ONCOLOGY REPORTS
- PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer
- (2017) Leslie Ann Caromile et al. Science Signaling
- Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: feasibility of an antibody-based companion diagnostic agent
- (2017) Bernadette V. Marquez-Nostra et al. Oncotarget
- Assessing the Racial and Ethnic Disparities in Breast Cancer Mortality in the United States
- (2017) Clement Yedjou et al. International Journal of Environmental Research and Public Health
- PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer
- (2017) Leslie Ann Caromile et al. Science Signaling
- High Intratumoral Stromal Content Defines Reactive Breast Cancer as a Low-risk Breast Cancer Subtype
- (2016) J. B. Dennison et al. CLINICAL CANCER RESEARCH
- 68Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients
- (2016) Mike Sathekge et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Preclinical Evaluation of 18F-Labeled Anti-HER2 Nanobody Conjugates for Imaging HER2 Receptor Expression by Immuno-PET
- (2016) G. Vaidyanathan et al. JOURNAL OF NUCLEAR MEDICINE
- Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants
- (2016) J.-P. Meyer et al. JOURNAL OF NUCLEAR MEDICINE
- Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer
- (2016) A. M. Fowler et al. JOURNAL OF NUCLEAR MEDICINE
- [89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer
- (2016) Richard Laforest et al. MOLECULAR IMAGING AND BIOLOGY
- Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT
- (2016) Jens Sörensen et al. Theranostics
- Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes
- (2016) Xiaofeng Dai et al. Journal of Cancer
- EMT in Breast Carcinoma—A Review
- (2016) Joema Felipe Lima et al. Journal of Clinical Medicine
- 68Ga-PSMA imaging of metastatic breast cancer
- (2015) Mike Sathekge et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- ImmunoPET of tissue factor expression in triple-negative breast cancer with a radiolabeled antibody Fab fragment
- (2015) Sixiang Shi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma
- (2015) M. Keyaerts et al. JOURNAL OF NUCLEAR MEDICINE
- PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles
- (2015) C. Perez-Medina et al. JOURNAL OF NUCLEAR MEDICINE
- Increased drug resistance in breast cancer by tumor-associated macrophages through IL-10/STAT3/bcl-2 signaling pathway
- (2015) Cuixia Yang et al. MEDICAL ONCOLOGY
- Role of the Tumor Microenvironment in Breast Cancer
- (2015) Savas D. Soysal et al. PATHOBIOLOGY
- Macrophage Involvement in Systemic Sclerosis: Do We Need More Evidence?
- (2015) Giuseppina Stifano et al. Current Rheumatology Reports
- Radioiodinated PARP1 tracers for glioblastoma imaging
- (2015) Beatriz Salinas et al. EJNMMI Research
- A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer Metastasis
- (2014) Shicheng Su et al. CANCER CELL
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Evaluation of 89Zr-pertuzumab in Breast Cancer Xenografts
- (2014) Bernadette V. Marquez et al. MOLECULAR PHARMACEUTICS
- Anti-tumor Effect of Integrin Targeted 177Lu-3PRGD2 and Combined Therapy with Endostar
- (2014) Jiyun Shi et al. Theranostics
- Imaging the Urokinase Plasminongen Activator Receptor in Preclinical Breast Cancer Models of Acquired Drug Resistance
- (2014) Aaron M. LeBeau et al. Theranostics
- Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers
- (2013) Alla Gabriella Wernicke et al. APMIS
- PET Imaging in Prostate Cancer: Focus on Prostate-Specific Membrane Antigen
- (2013) Ronnie C. Mease et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- 89Zr-Bevacizumab PET Imaging in Primary Breast Cancer
- (2013) S. B. M. Gaykema et al. JOURNAL OF NUCLEAR MEDICINE
- Anti-Prostate-Specific Membrane Antigen Liposomes Loaded with 225Ac for Potential Targeted Antivascular -Particle Therapy of Cancer
- (2013) A. Bandekar et al. JOURNAL OF NUCLEAR MEDICINE
- Progesterone receptor targeting with radiolabelled steroids: An approach in predicting breast cancer response to therapy
- (2013) Susana Cunha et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Assessment of the Novel Estrogen Receptor PET Tracer 4-Fluoro-11β-methoxy-16α-[18F]fluoroestradiol (4FMFES) by PET Imaging in a Breast Cancer Murine Model
- (2013) Michel Paquette et al. MOLECULAR IMAGING AND BIOLOGY
- Expression of VEGF and Semaphorin Genes Define Subgroups of Triple Negative Breast Cancer
- (2013) R. Joseph Bender et al. PLoS One
- Tumor-associated macrophages: functional diversity, clinical significance, and open questions
- (2013) Subhra K. Biswas et al. Seminars in Immunopathology
- Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network
- (2012) Nancy U. Lin et al. CANCER
- Nanobody-Based Targeting of the Macrophage Mannose Receptor for EffectiveIn VivoImaging of Tumor-Associated Macrophages
- (2012) Kiavash Movahedi et al. CANCER RESEARCH
- The Ubiquitin-Proteasome System Meets Angiogenesis
- (2012) N. Rahimi MOLECULAR CANCER THERAPEUTICS
- Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
- (2012) Qiong-wen Zhang et al. PLoS One
- The role of nuclear medicine in modern therapy of cancer
- (2012) Gabriela Kramer-Marek et al. TUMOR BIOLOGY
- Integrin α3β1 as a breast cancer target
- (2011) Sita Subbaram et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Detection of prostate-specific membrane antigen on HUVECs in response to breast tumor-conditioned medium
- (2011) Berkman INTERNATIONAL JOURNAL OF ONCOLOGY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- HER2 Evaluation and Its Impact on Breast Cancer Treatment Decisions
- (2011) K.A.B. Goddard et al. Public Health Genomics
- Bevacizumab in the Treatment of Metastatic Breast Cancer: Friend or Foe?
- (2011) Alberto J. Montero et al. Current Oncology Reports
- Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice
- (2009) Angélica M. Santos et al. JOURNAL OF CLINICAL INVESTIGATION
- Sentinel lymph node accumulation of Lymphoseek and Tc-99m-sulfur colloid using a “2-day” protocol
- (2009) Anne M. Wallace et al. NUCLEAR MEDICINE AND BIOLOGY
- Quantitative Imaging of Estrogen Receptor Expression in Breast Cancer with PET and 18F-Fluoroestradiol
- (2008) L. M. Peterson et al. JOURNAL OF NUCLEAR MEDICINE
- Patterns of v 3 Expression in Primary and Metastatic Human Breast Cancer as Shown by 18F-Galacto-RGD PET
- (2008) A. J. Beer et al. JOURNAL OF NUCLEAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started